PHARMAKODEX
PharmaKodex is a pharmaceutical company that develops and commercializes small molecule drugs for treating pain and neurological conditions. The company was founded in 2006 and is based in Cambridge, the United Kingdom with an additional office in Chippenham, the United Kingdom. As of February 23, 2009, PharmaKodex Ltd. operates as a subsidiary of Orexo AB.
PHARMAKODEX
Social Links:
Industry:
Biotechnology Hospital Manufacturing Medical Pharmaceutical
Founded:
2006-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Status:
Active
Contact:
44 1223 421601
Total Funding:
7.1 M GBP
Similar Organizations
Gurus BioPharm
Gurus BioPharm is a pharmaceutical company that develops innovative drugs combining two molecules namely prostaglandins and nitric oxide.
Investors List
SR One
SR One investment in Series A - PharmaKodex
Unilever Ventures
Unilever Ventures investment in Series A - PharmaKodex
Apposite Capital
Apposite Capital investment in Series A - PharmaKodex
More informations about "PharmaKodex"
PharmaKodex Company Profile 2024: Valuation, Investors
PharmaKodex is headquartered in Chippenham, United Kingdom. What is the size of PharmaKodex? PharmaKodex has 2 total employees. What industry is PharmaKodex in? …See details»
PharmaKodex - VentureRadar
Drug delivery company PharmaKodex Limited was created in 2006 as a spin-out from Vectura Group and Unilever. With its expertise in the reformulation and development of prescription …See details»
PharmaKodex - Products, Competitors, Financials, Employees ...
PharmaKodex is a spin-out from Vectura Group and Unilever to exploit drug delivery and enabling formulation technologies in developing faster acting, more convenient or more effective …See details»
PharmaKodex Ltd. - Drug pipelines, Patents, Clinical trials - Synapse
Explore PharmaKodex Ltd. with its drug pipeline, therapeutic area, technology platform, , Drug:PKX-462, PKX-899, PKX-387, PKX-963, PKX-426.See details»
Orexo AB Acquires a UK Drug Delivery Company, PharmaKodex Ltd.
Feb 23, 2009 More about PharmaKodex . PharmaKodex was spun out from Vectura Group plc and Unilever plc in May 2006 to develop the proprietary formulation and delivery product …See details»
PharmaKodex - Funding, Financials, Valuation & Investors
PharmaKodex is a pharmaceutical company that develops and commercializes small molecule drugs for treating pain and neurological conditions. Search Crunchbase. Start Free Trial . …See details»
PharmaKodex - Drug pipelines, Patents, Clinical trials - Synapse
Explore PharmaKodex with its drug pipeline, therapeutic area, technology platform, .See details»
PharmaKodex Ltd. - Scrip
Apr 1, 2007 PharmaKodex, a joint venture of Vectura Group and Unilever Ventures, is developing oral and dermal delivery systems that improve availability, thus improving drug …See details»
PharmaKodex - Crunchbase
PharmaKodex is a pharmaceutical company that develops and commercializes small molecule drugs for treating pain and neurological conditions. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. …See details»
PharmaKodex - Company Profile - Tracxn
PharmaKodex - Proprietary platform for drug delivery and drug reformulation. Raised a total funding of $13.5M over 1 round from 2 investors. PharmaKodex has 3234 competitors.See details»
PharmaKodex Ltd.:Company Profile & Technical …
PharmaKodex Ltd. is a company that provides Small molecule, Medicine, Drug and more. PharmaKodex Ltd. is headquartered in United Kingdom . PharmaKodex Ltd. was founded in …See details»
PharmaKodex Ltd. - life-sciences-europe.com
Top News. Digital Drug Company Nuuron Secures €3.5m Seed Round; Aignostics Secures $34m Series B Round Led by Athos; Inbrain Neuroelectronics: $50m Series B Led by imec.xpandSee details»
PHARMAKODEX LTD innovation strategy - GoodIP
PHARMAKODEX LTD has a total of 58 patent applications. Its first patent ever was published in 2001. It filed its patents most often in United Kingdom, EPO (European Patent Office) and …See details»
PKX-387 - Drug Targets, Indications, Patents - Synapse - Patsnap
PKX-387, Initially developed by PharmaKodex Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Nervous System Diseases,Other Diseases. ... Originator …See details»
Orexo acquires PharmaKodex - 2009-02-23 - Crunchbase
PharmaKodex PharmaKodex is a pharmaceutical company that develops and commercializes small molecule drugs for treating pain and neurological conditions. Acquiring Organization: …See details»
PKX-462 - Drug Targets, Indications, Patents - Synapse - Patsnap
PKX-462, Initially developed by PharmaKodex Ltd., Now, its global highest R&D status is Discontinued, Therapeutic Areas: Nervous System Diseases. ... Originator Organization. …See details»
PKX-899 - Drug Targets, Indications, Patents - Synapse
PKX-899, Initially developed by PharmaKodex Ltd., Now, its global highest R&D status is Pending, Therapeutic Areas: Infectious Diseases. ... Originator Organization. PharmaKodex …See details»